An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4.
Federica Pericle(University of Turin), G Forni(University of Turin), Andrea Modesti(Immungenetics (Germany)), Francesco Novelli(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Francesco Di Pierro(University of Insubria), Mario P. Colombo(University of Palermo), Giuliana Ferrari(Vita-Salute San Raffaele University), Federica Cavallo(University of Turin), Mirella Giovarelli(Immungenetics (Germany)), Piero Musiani(Immungenetics (Germany))
Cited by 129
Related Papers
A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction
|Cell|1992|1.3k
The Battle of the Water Sensor Networks (BWSN): A Design Challenge for Engineers and Algorithms
|Journal of Water Resources Planning and Management|2008|583
Classification of current anticancer immunotherapies
|Oncotarget|2014|469